Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

被引：0

作者：

Yunsik Choi

Sanghyuk Lee

Kapyoul Kim

Soo-Hyun Kim

Yeun-Jun Chung

Charles Lee

机构：

[1] Ewha Womans University,Department of Life Sciences

[2] The Catholic University of Korea,Department of Microbiology, Precision Medicine Research Center, IRCGP, College of Medicine

[3] The Jackson Laboratory for Genomic Medicine,undefined

来源：

Experimental & Molecular Medicine | 2018年 / 50卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.

引用

页码：1 / 9

页数：8

共 50 条

[31] Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines
Xing Yi Woo
Anuj Srivastava
Joel H. Graber
Vinod Yadav
Vishal Kumar Sarsani
Al Simons
Glen Beane
Stephen Grubb
Guruprasad Ananda
Rangjiao Liu
Grace Stafford
Jeffrey H. Chuang
Susan D. Airhart
R. Krishna Murthy Karuturi
Joshy George
Carol J. Bult
BMC Medical Genomics, 12
[32] Engraftment of patient derived xenografts on mice with a humanized immune system
Wulf-Goldenberg, Annika
Stecklum, Maria
Eckert, Klaus
Behrens, Diana
Fichtner, Iduna
Hoffmann, Jens
CANCER RESEARCH, 2015, 75
[33] Development and validation of humanized mice models implanted with patient derived colorectal cancer xenografts
Capasso, Anna
Lang, Julie
Pitts, Todd M.
Davis, Sarah Lindsey
Lieu, Christopher
Kopetz, Scott
Bagby, Stacey
Francoeur, Paul
Tentler, John J.
Slansky, Jill
Pelanda, Roberta
Eckhardt, Gail
CANCER RESEARCH, 2017, 77
[34] Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients
Affatato, Roberta
Mendogni, Paolo
Del Gobbo, Alessandro
Ferrero, Stefano
Ricci, Francesca
Broggini, Massimo
Rosso, Lorenzo
CANCERS, 2020, 12 (12) : 1 - 13
[35] An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
Cho, Sung-Yup
Kang, Wonyoung
Han, Jee Yun
Min, Seoyeon
Kang, Jinjoo
Lee, Ahra
Kwon, Jee Young
Lee, Charles
Park, Hansoo
MOLECULES AND CELLS, 2016, 39 (02) : 77 - 86
[36] Patient-derived tumor xenografts (PDXs) recapitulate the antitumor activity of novel therapies in metastatic breast cancer (MBC) patients (pts)
Oliveira, Mafalda
Pascual, Javier
Cruz, Cristina
Gris, Alberto
Palafox, Marta
Llop, Alba
Castroviejo, Marta
Viaplana, Cristina
Ibrahim, Yasir H.
Arribas, Joaquin
Cortes, Javier
Baselga, Jose
Rodon, Jordi
Balmana, Judith
Dienstmann, Rodrigo
Saura, Cristina
Serra, Violeta
CANCER RESEARCH, 2017, 77
[37] Preclinical model of patient derived tumor transplant in humanized mice for cancer immunotherapy
Wulf-Goldenberg, Annika
Stecklum, Maria
Fichtner, Iduna
Hoffmann, Jens
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
[38] Feasibility and relevance of "animal clinical trials" using breast cancer patient-derived xenografts (PDX) in mice
Lewis, Michael T.
Dobrolecki, Lacey E.
Petrovic, Ivana
Hilsenbeck, Susan G.
CANCER RESEARCH, 2015, 75
[39] Preclinical evaluation of Braftovi (encorafenib) plus Mektovi (binimetinib) in NRAS mutated patient-derived xenografts (PDXs)
Niessner, H.
Huesch, A.
Meinhardt, M.
Westphal, D.
Meier, F.
Schilling, B.
Sinnberg, T.
EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E101 - E101
[40] Immune checkpoint inhibitor responses in humanized mouse melanoma models using patient-derived xenografts.
Somasundaram, Rajasekharan
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)

← 1 2 3 4 5 →